We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+561.53%
AUM
$1.67T
AUM Growth
+$23.3B
Cap. Flow
-$2.36B
Cap. Flow %
-0.14%
Top 10 Hldgs %
22.15%
Holding
8,587
New
427
Increased
3,946
Reduced
2,962
Closed
384

Sector Composition

Rank Sector Weight
1 Technology 22.44%
2 Financials 11.14%
3 Consumer Discretionary 8.06%
4 Healthcare 8.02%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GFF icon
2526
Griffon
GFF
$4.8B
$31.4M ﹤0.01%
426,591
+87,716
+26% +$6.52M
TFII icon
2527
TFI International
TFII
$12.1B
$31.4M ﹤0.01%
303,800
-266,119
-47% -$24.8M
MNRO icon
2528
Monro
MNRO
$352M
$31.4M ﹤0.01%
1,566,559
-147,895
-9% -$2.72M
CXW icon
2529
CoreCivic
CXW
$3.13B
$31.4M ﹤0.01%
1,642,663
-311,572
-16% -$5.71M
IRDM icon
2530
Iridium Communications
IRDM
$5.27B
$31.2M ﹤0.01%
1,795,202
-43,028
-2% -$760K
LXP icon
2531
LXP Industrial Trust
LXP
$3.58B
$31.2M ﹤0.01%
629,099
+50,058
+9% +$2.4M
PXH icon
2532
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.96B
$31.2M ﹤0.01%
1,208,404
+149,537
+14% +$3.85M
SFNC icon
2533
Simmons First National
SFNC
$3.46B
$31.2M ﹤0.01%
1,653,394
+27,078
+2% +$502K
COCO icon
2534
Vita Coco
COCO
$3.77B
$31M ﹤0.01%
585,439
+23,264
+4% +$1.09M
FBK icon
2535
FB Financial Corp
FBK
$3.1B
$31M ﹤0.01%
555,090
+126,706
+30% +$7.08M
RNST icon
2536
Renasant Corp
RNST
$4B
$30.9M ﹤0.01%
877,230
+166,246
+23% +$5.89M
IBHI icon
2537
iShares iBonds 2029 Term High Yield and Income ETF
IBHI
$499M
$30.9M ﹤0.01%
1,306,212
+60,056
+5% +$1.42M
PCRX icon
2538
Pacira BioSciences
PCRX
$924M
$30.9M ﹤0.01%
1,192,594
+49,832
+4% +$1.18M
HYBL icon
2539
State Street Blackstone High Income ETF
HYBL
$575M
$30.9M ﹤0.01%
1,085,063
+480,821
+80% +$13.7M
FRSH icon
2540
Freshworks
FRSH
$3.51B
$30.8M ﹤0.01%
2,516,355
+1,166,814
+86% +$13.8M
AAP icon
2541
Advance Auto Parts
AAP
$3.46B
$30.8M ﹤0.01%
783,539
-75,487
-9% -$3.78M
VCTR icon
2542
Victory Capital Holdings
VCTR
$7.27B
$30.8M ﹤0.01%
487,929
-182,586
-27% -$11.6M
EZM icon
2543
WisdomTree US MidCap Fund
EZM
$960M
$30.7M ﹤0.01%
459,278
-3,401
-0.7% -$225K
ABM icon
2544
ABM Industries
ABM
$2.82B
$30.7M ﹤0.01%
724,716
-38,684
-5% -$1.7M
SITE icon
2545
SiteOne Landscape Supply
SITE
$4.27B
$30.6M ﹤0.01%
245,944
+15,130
+7% +$1.92M
DSL
2546
DoubleLine Income Solutions Fund
DSL
$1.24B
$30.6M ﹤0.01%
2,718,268
-393,810
-13% -$4.55M
HRMY icon
2547
Harmony Biosciences
HRMY
$2.24B
$30.6M ﹤0.01%
817,507
-30,388
-4% -$999K
ACAD icon
2548
Acadia Pharmaceuticals
ACAD
$4.89B
$30.5M ﹤0.01%
1,141,974
-46,432
-4% -$1.11M
DOCN icon
2549
DigitalOcean
DOCN
$15.6B
$30.4M ﹤0.01%
632,588
-324,429
-34% -$14.3M
AZTA icon
2550
Azenta
AZTA
$1.49B
$30.4M ﹤0.01%
913,182
-28,178
-3% -$921K

Similar funds

Morgan Stanley's Q4 2025 Portfolio in Review

As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Morgan Stanley's Q4 2025 filing shows 427 new, 3,946 increased, 2,962 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
  • Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
  • Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
  • Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
  • Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
  • Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
  • Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.

Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.